Ponazuril Toltrazuril Sulfone Ponazuril Manufacture
Production Advantage
We are committed to R&D and production of high quality and differentiated veterinary preparations. The main products are antibiotics and anticoccidial drugs, as Tylosin, Salinomycin, Tilmicosin, Tiamulin, Tylvalosin, Flunixin Meglumine, Clopidol, Diclazuril, Toltrazuril, Ponazuril, etc. We gain high reputation in the market, and recognition among customers.
Advantage service
1.Sample: Supply sample before cooperation
2.Package: Can be prepared according the customers` requirement
3.Price: Competitive price
4.Documents: Commerical invoice, packing list, BL, CoA and other documents if you have special requirements.
5.Delivery: Prompt shipment after Commodity Inspection.
6.Shipment: Long-term stable cooperation with forwarders and agent, by Sea, Air and Express.
Name |
Ponazuril |
CAS |
69004-04-2 |
Synonyms |
Ponazuril;ToltrazurilSulfone;1-Methyl-3-{3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl}-1, 3,5-triazine-2,4,6(1H,3H,5H)-trione;Ponazuril [inn];Unii-jpw84as66u |
MF |
C18H14F3N3O6S |
MW |
457.38 |
Others |
Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona.[1][2] More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM. |
Appearance | White or off white Crystalline powder | white Crystalline powder |
IR | IR spectrum of sample corresponds to that of reference Standard | Conform |
Melting point | 241~246℃ | 243.0~245.1℃ |
Heavy Metals | not more than 10ppm | <10ppm |
Sulphated ash | not more than 0.5% | 0.50% |
Loss on drying | not more than 0.5% | 0.02% |
Assay(HPLC) | not less than 98.0 percent (Anhydrous substance) | 98.55% |
Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona.[1][2] More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View